Orbimed Advisors LLC Amgen Inc Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Orbimed Advisors LLC holds 252,300 shares of AMGN stock, worth $72.6 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares

252,300

Previous 134,900 87.03%

Holding current value

$72.6 Million

Previous $42.1 Million 92.87%

% of portfolio

1.92%

Previous 1.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $36.3 Million - $39.6 Million	117,400 Added 87.03%	252,300 $81.3 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $18.8 Million - $22.8 Million	71,500 Added 112.78%	134,900 $42.1 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $17.2 Million - $20.7 Million	-63,900 Reduced 50.2%	63,400 $18 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $10.8 Million - $12.8 Million	50,600 Added 65.97%	127,300 $28.3 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $17.3 Million - $21.1 Million	76,700 New	76,700 $18.5 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $8.04 Million - $8.91 Million	-34,400 Reduced 37.6%	57,100 $13.9 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $2.71 Million - $3.33 Million	-13,700 Reduced 13.02%	91,500 $21.6 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $3.08 Million - $4.08 Million	-16,900 Reduced 13.84%	105,200 $21.3 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $5.26 Million - $6.14 Million	-29,500 Reduced 19.46%	122,100 $23.8 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $5.1 Million - $5.74 Million	27,500 Added 22.16%	151,600 $31.4 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $53.3 Million - $59.9 Million	-321,210 Reduced 72.13%	124,100 $22.9 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $144 Million - $169 Million	-851,790 Reduced 65.67%	445,310 $75.9 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $7.43 Million - $8.3 Million	44,000 Added 3.51%	1,297,100 $226 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $210 Million - $239 Million	1,253,100	1,253,100 $234 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Amgen Inc Transaction History